Med-tech company leveraging orthopedic bracing technology to improve mobility and reduce pain.
Med-tech company leveraging orthopedic bracing technology to improve mobility and reduce pain. Headquartered in Charlottesville, VA. Raised $7.2M in Series A funding in June 2026 led by Riptide Ventures.
Healthcare📍 Charlottesville, VA
Current Valuation
Private
PRIVATE
IPO Outlookprivate
Is Icarus Medical going public?
No. Icarus Medical is private and has not filed to go public. There is no S-1 on file.
What is Icarus Medical's valuation in 2026?
No confirmed valuation is on record for Icarus Medical. The roster shows funding and investors where they are public; it does not estimate a mark.
Has Icarus Medical filed an S-1?
No public S-1 is on file for Icarus Medical.
Who are Icarus Medical's investors?
Icarus Medical's investors include Riptide Ventures, OSF Ventures, CU Healthcare Innovation Fund, Highpoint Ventures, MedTech Connect, Neovate Capital Partners and 1 more.
How much has Icarus Medical raised?
Icarus Medical has raised $7.2M in total across 1 disclosed round, most recently a Series A of $7.2M in Jun 2026.
Is Icarus Medical publicly traded — can you buy Icarus Medical stock?
No. Icarus Medical is a private company — its shares are not listed on any exchange and there is no ticker. The routes to exposure are pre-IPO secondary marketplaces and funds (accredited investors), employee tender offers when the company runs one, and public companies with read-through exposure. QuantLogix maps every route it can verify for Icarus Medical on its Pre-IPO Access Desk.
Answers are derived from the roster record shown on this page — filing status, last round and confirmed marks. Where the record is silent, the answer says so rather than guessing.
Company Profile
CEO
Dave Johnson
HQ
Charlottesville, VA
Total Raised
$7.2M
Last Round
Series A — $7.2M (Jun 2026) · Lead: Riptide Ventures
IPO Status
private
Fundraising Status
Series A · $7.2M · 5 mo ago
privateTotal raised $7.2M1 disclosed rounds
Funding History
Round
Amount
Date
Lead Investor
Post-Money
Series A
$7.2M
Jun 2026
Riptide Ventures
—
Talent Signal
Hiring trend
▼ Hiring downtrend
-85% vs 2026-09
Open roles
6
via careers page
Product-build share
33%
engineering, research, product, design
Trajectory
tightening
balanced build + GTM — 33% builders vs 67% go-to-market/G&A — scaling both sides.
Open roles trending down; no tracked executive churn.
Open roles by month
Open roles by function
■ product-building ■ go-to-market / G&A
![Icarus Medical Logo - White TextICARUS Medical InnovationsSkip to contentPost-Operative SupportAccounting ManagerSocial Media & Growth Manager
Counted from Icarus Medical's live job board as of 2026-10-14; role functions classified from posting titles. Open-role counts are an activity signal, not headcount. Refreshed monthly.
Founders & Key People
Dave Johnson
Investors
Riptide Ventures · OSF Ventures · CU Healthcare Innovation Fund · Highpoint Ventures · MedTech Connect · Neovate Capital Partners · BLU Venture Investors
HealthcareMedical TechnologyRecently Funded
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.